Table 3 Types of IP based on the Anatomical, Therapeutic, and Chemical (ATC) classification
From: Improving individualized prescription in patients with multimorbidity through medication review
ATC group | Number of IP identified | Number of proposals applied | % of proposals applied |
|---|---|---|---|
A–Alimentary tract and metabolism | 330 (24.7%) | 232 | 70.3% |
B–Blood and blood-forming organs | 124 (9.3%) | 88 | 71.0% |
C–Cardiovascular system | 412 (30.8%) | 267 | 64.8% |
D–Dermatological | 0 | 0 | 0 |
G–Genitourinary system and hormones | 26 (1.9%) | 17 | 65.4% |
H–Systemic hormonal preparations (Excluding sex hormones and insulin) | 7 (0.5%) | 4 | 57.1% |
J–Anti-infective for systemic use | 1 (0.1%) | 0 | 100% |
L–Antineoplastic and immunomodulation agents | 2 (0.2%) | 2 | 100% |
M–Musculoskeletal system | 28 (2.3%) | 17 | 60.7% |
N–Nervous system | 329 (24.6%) | 187 | 56.8% |
R–Respiratory system | 69 (5.1%) | 46 | 66.7% |
S–Sensory organs | 6 (0.4%) | 4 | 66.7% |
V–Various | 0 | 0 | 0 |
TOTAL | 1334 | 864 |